Sylvius

The Leiden Early Drug Discovery & Development (LED3) network is a collaboration between Leiden University’s Institute of Biology (IBL), Leiden Institute of Chemistry (LIC), and the Leiden Academic Centre for Drug Research (LACDR). LED3 drives the discovery of innovative drug targets, molecules, and concepts to develop safer, more effective treatments for diseases like cancer, cardiovascular, […]